Transdifferentiation of mesenchymal stromal cells into myelinating lemmocyte-like cells

Citar

Texto integral

Acesso aberto
Acesso é fechado

Acesso está concedido
Acesso é fechado

Acesso é pago ou somente para assinantes

Autor responsável pela correspondência
Email: redaktor@celltranspl.ru
Rússia

Akiyama Y., Radtke С., Kocsis J.D. Remyelination of the rat spinal cord by transplantation of identifed bone marrow stromal cells. J. Neurosci 2002; 22: 6623-30.
Berger P., Sirkowski E.E., Scherer S., Suter U. Expression analysis of the N-Мус downstream-regulated gene 1 indicates that myelinating Schwann cells are the primary disease target in hereditary motor and sensory neuropathy-Lom. Neurobiol. Dis. 2004; 17: 290-9.
Bianco P., Riminucci M., Gronthos S., Robey P.G. Bone marrow stromal cells: nature, biology, and potential applications. Stem Cells 2001; 19:180-92.
Brustle 0., Jones K.N., bearish R.D. et al. Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science 1999; 285: 754-6.
Fansa H., Keilhoff G. A comparison of different biogenic matrices seeded with cultured Schwann cells for bridging peripheral nerve defects. Neurol. Res. 2004;26:167-73.
Fansa H., Keilhoff G., Wolf G., Schneider W. Tissue engineering of peripheral nerves: a comparison of venous and acellular muscle grafts with cultured Schwann cells. Plast. Reconstr. Surg. 2001; 107: 485- 94.

Ação

1. JATS XML